Endo Pharmaceuticals whistleblower Peggy Ryan has been awarded $33.6 million as a result of the qui tam complaint she filed against the company in 2005. Ryan’s payout constitutes roughly 24% of the federal government’s cut of the $171.9 million settlement Endo agreed to pay for illegally promoting the drug Lidoderm for off-label use.
While the U.S. Government disputes the 24% figure, arguing that she should receive only 19%, U.S. District Judge Robert F. Kelly ruled that Ryan’s “extraordinary” contributions to the near decade-long litigation merited a larger sum. In his memorandum, Judge Kelly noted that Ryan “nurtured the flame at the darkest times when a favorable outcome seemed most remote” and “enabled the government investigatory team to recover evidence which would have otherwise been unobtainable”.
In a statement to the Legal Intelligencer, Peggy Ryan’s attorney wrote, “It is never easy to be a whistleblower, especially when a case goes on for a decade, but Ms. Ryan has remained dedicated to the cause of exposing fraud…We hope Judge Kelly’s decision to grant Ms. Ryan close to the maximum percentage will encourage other individuals with evidence of fraud against the government to come forward.”
Philadelphia Whistleblower Lawyers at Sidkoff, Pincus & Green protect those who expose Fraudulent Government Practices
Qui Tam Lawyers in Philadelphia at Sidkoff, Pincus & Green have extensive experience protecting whistleblowers who have evidence of fraud against the government. Whistleblowers often have information and evidence that would otherwise be unobtainable, however it takes a great deal of courage to come forward. Our Philadelphia whistleblower lawyers understand that disclosing fraudulent behavior puts employees in a vulnerable position. For knowledgeable legal counsel regarding whistleblower actions, call our Philadelphia, Pennsylvania law offices at 215-574-0600 to schedule a consultation or submit an inquiry online.